Join hundreds of clinics and acquire new patients from abroad. Please fill out the form and we will get back to you within 2 days.
Added by Klaudia Futyma on 26.08.2025
Paradoxical Adipose Hyperplasia (PAH) is a rare but significant complication associated with cryolipolysis treatments like CoolSculpting. Unlike typical fat reduction outcomes where treated areas diminish in size, PAH results in an unexpected increase in fat volume, creating firm, bulging masses underneath the skin. These fat deposits are often described as firm, rubbery, and sometimes resembling a “stick of butter” due to their texture and appearance. Such growths are usually asymmetrical and can occur months after the initial procedure, often catching patients and practitioners off guard. The underlying cause of PAH remains a topic of ongoing research, but it is believed to involve a paradoxical response of fat cells to the cooling process, leading to their proliferation rather than destruction. It is crucial for patients to understand this potential risk before opting for cryolipolysis, especially since PAH can be resistant to non-surgical treatments and may require surgical intervention for correction.
Advanced technologies like CoolSculpting Elite come with a premium price, but treat larger surface areas per session effectively.
In standard CoolSculpting procedures, targeted fat cells are exposed to controlled cooling, which triggers apoptosis—the natural death of fat cells—without harming surrounding tissues. Over time, the body’s lymphatic system processes and eliminates these dead cells, resulting in a noticeable reduction in fat volume in the treated area. This process is generally safe, with minimal side effects and predictable results, making it a popular choice for body contouring. However, in cases of PAH, instead of shrinking, the fat cells in the treated region undergo a paradoxical response where they proliferate or enlarge, creating a firm, bulging mass rather than shrinking. This reaction occurs despite the cooling being within the recommended parameters. The exact mechanism behind this anomaly is not fully understood, but it highlights how individual biological responses can vary significantly. The reaction can develop months after treatment, leading to unexpected aesthetic concerns that can be distressing for patients expecting typical results from the procedure.
The case of Linda Evangelista, a renowned supermodel, brought widespread attention to the risks associated with CoolSculpting, particularly PAH. Evangelista publicly shared her experience of undergoing the treatment to reduce stubborn fat in her thighs and hips. Instead of the desired slimming effect, she developed a large, persistent, and unsightly bulge, which she described as a “puffy” and unwanted growth. Her story underscores the fact that even high-profile individuals with access to advanced medical care are not immune to rare complications like PAH. Linda’s case became a catalyst for increased awareness and scrutiny of cryolipolysis procedures, emphasizing the importance of informed consent and thorough consultation before undergoing body contouring treatments. Her experience also sparked discussions within the aesthetic community about the need for safer techniques and better patient education on potential risks.
One of the most distinctive features of PAH is the appearance of the affected area. The fat bulges are often described as firm, doughy, or rubbery, with a consistency that feels different from normal fat deposits. They are usually localized to the treated area, presenting as a well-defined, sometimes symmetrical, or asymmetrical mass that can resemble a “stick of butter” under the skin. The skin over these bulges often appears normal, with no significant redness or discoloration, but the firmness and shape are markedly different from the surrounding tissue. Patients may notice the development of these bulges several months after their cryolipolysis treatment, and they tend to be resistant to diet or exercise, making them particularly frustrating. The visual similarity to a block of butter, coupled with the firmness of the bulges, makes PAH quite distinctive and often concerning for those affected, as it can significantly alter body contour and self-image.
The occurrence of PAH is influenced by a combination of factors, including gender, device used, and individual genetic predispositions. Research indicates that males may have a slightly higher risk of developing PAH after cryolipolysis, possibly due to differences in fat cell distribution and biological responses to cold exposure. The specific device or applicator used during treatment can also play a role; some devices may deliver cooling more aggressively or unevenly, increasing the risk of paradoxical responses. Additionally, genetic factors might influence how fat cells react to cold temperatures, with some individuals being genetically predisposed to abnormal proliferation. Other risk factors include the treatment area—such as the abdomen or flanks, which contain different fat structures and blood flow characteristics—and the practitioner’s experience and technique. Understanding these factors can help patients make more informed decisions and potentially reduce their risk of experiencing PAH.
While PAH is considered a rare complication, the true prevalence remains somewhat uncertain due to underreporting and variability in clinical experiences. Manufacturer-reported rates are generally low, often cited as less than 1% of treated patients, but independent studies and patient reports suggest that the actual incidence may be higher. Many cases go unreported because patients or practitioners may not recognize the condition early, or they might attribute it to other causes such as weight gain or natural fat distribution. Some clinics and researchers estimate that PAH could affect up to 2-5% of individuals undergoing cryolipolysis, especially in certain populations or treatment areas. This discrepancy highlights the need for better data collection, standardized reporting, and increased awareness among practitioners and patients. Accurate assessment of how common PAH is will help in developing safer protocols and patient screening methods, ultimately reducing its occurrence.
Typically, symptoms of PAH become noticeable several months after the initial cryolipolysis treatment, with most cases reported between three to six months post-procedure. The timeline varies depending on individual healing responses, the area treated, and the cooling protocol used. Patients often first notice a firm, bulging mass that was not present before treatment, which may gradually enlarge over time. The appearance of these bulges is sometimes delayed because initial swelling or inflammation from the procedure can mask the development of PAH. In some instances, the fat growth might be mistaken for weight gain or natural fat redistribution, leading to delays in diagnosis. Early recognition is crucial for managing expectations and planning subsequent treatment options, such as liposuction or other surgical interventions, which may be necessary to correct the deformity.
Contrary to some misconceptions, diet and exercise are generally ineffective in reversing PAH. Since the condition involves an abnormal proliferation of fat cells rather than an increase in the size of existing cells, traditional weight loss methods do not address the root cause. Patients who attempt to reduce the bulges through dieting or vigorous exercise often find little to no improvement, leading to frustration and disappointment. The hardened, fibrous nature of the PAH fat deposits makes them resistant to non-invasive treatments. This reality underscores the importance of early diagnosis and considering surgical options if correction is desired. It also highlights the need for patients to have realistic expectations about the outcomes of non-surgical body contouring procedures and to understand that some complications may require more invasive solutions.
The primary treatment for PAH involves surgical intervention, most commonly liposuction. Liposuction allows the removal of the abnormal fat deposits directly, providing a more definitive solution to the deformity caused by PAH. The procedure is typically performed under local anesthesia and involves inserting a cannula through small incisions to suction out the fibrous, firm fat. In some cases, additional procedures such as skin tightening or contouring may be necessary to achieve optimal aesthetic results. It is important for patients to consult with experienced plastic surgeons or aesthetic surgeons who are familiar with PAH management to ensure safe and effective removal. While liposuction is generally successful, it requires careful planning and technique to avoid further complications and to achieve symmetry and natural-looking results.
Experiencing PAH can be emotionally taxing for patients, especially considering the initial expectations of body contouring procedures like CoolSculpting. The unexpected development of firm, bulging fat deposits can lead to feelings of disappointment, embarrassment, and diminished self-confidence. For some, these physical changes may cause psychological distress, impacting daily life and social interactions. The frustration of unsuccessful non-invasive treatments and the potential need for surgery can also contribute to anxiety and emotional strain. It is vital for practitioners to provide comprehensive counseling and support, emphasizing realistic outcomes and exploring options for correction. Patients should also be encouraged to seek mental health support if they experience significant emotional distress related to treatment complications. Recognizing the emotional impact of PAH is essential for holistic patient care and recovery.
Comprehensive medical travel packages make the entire vaginoplasty journey smoother, from the first online consultation to post-surgery aftercare in comfort
Given the risks associated with cryolipolysis, including the potential for PAH, patients may consider alternative body-sculpting treatments with different mechanisms of action and safety profiles. For example, SculpSure uses laser technology to heat and destroy fat cells, which are then naturally eliminated by the body. This method has a different risk profile and does not involve cold temperatures that could trigger paradoxical fat growth. Other options like radiofrequency or ultrasound-based treatments also offer non-invasive fat reduction with a lower incidence of adverse effects. When choosing a treatment, it is essential to research the technology, review clinical studies, and consult with qualified practitioners. Selecting clinics with experienced staff and proper safety protocols can significantly reduce the likelihood of complications like PAH and ensure satisfactory outcomes.
Patients should be proactive in vetting clinics and practitioners to minimize risks associated with body contouring procedures. Key questions include asking about the practitioner’s experience with the specific treatment, the number of procedures performed, and their complication rates. It is also important to inquire about the technology used and whether it has been approved by relevant health authorities. Patients should ask about potential side effects and how complications like PAH are managed. Additionally, requesting before-and-after photos of previous patients can provide insight into the practitioner’s skill and results. Ensuring the clinic follows strict hygiene protocols and provides thorough pre-treatment consultations will contribute to a safer experience. Ultimately, choosing a reputable, well-trained provider is crucial for achieving safe and effective outcomes.
Paradoxical adipose hyperplasia (PAH) is a rare complication of cryolipolysis treatments like CoolSculpting, characterized by an unexpected increase in fat volume in the treated area, forming firm, bulging masses that resemble a “stick of butter.”
Linda Evangelista’s case of PAH was an unexpected outcome after her cryolipolysis procedure, leading to the development of a prominent, firm fat bulge in her treated area, which she publicly shared to raise awareness about this rare side effect.
Before PAH, the treated area appears normal or slightly swollen, but after, it shows a firm, well-defined bulge or mass that can be mistaken for natural fat or weight gain, often resistant to diet and exercise.
The incidence of PAH is estimated to be less than 1% based on manufacturer reports, but some studies suggest it could be higher, up to 2-5%, especially with certain patient profiles or treatment parameters.
Higher risk groups include males, individuals with specific genetic predispositions, and those treated with certain devices or techniques that may deliver more aggressive cooling.
No, PAH fat bulges are resistant to diet and exercise because they involve an abnormal proliferation of fat cells, often requiring surgical removal for correction.
The primary treatment involves liposuction, which effectively removes the abnormal fat deposits, providing a significant improvement in contour and appearance.
PAH can lead to emotional distress, decreased self-confidence, and social anxiety, especially if the deformity persists or worsens over time, impacting overall quality of life.
Yes, alternatives such as SculpSure, radiofrequency, and ultrasound-based treatments offer non-invasive fat reduction options with lower risks of paradoxical fat growth.
Patients should seek experienced practitioners, inquire about complication rates, choose approved technologies, and consider alternative treatments with safer profiles to reduce the risk of PAH.
Klaudia began working at Clinic Hunter shortly after graduating from the John Paul II Catholic University of Lublin, and over the years, this role has become her greatest passion. She has gained valuable experience by supporting patients from around the world—mainly the UK, Scandinavia, and the US—while also building strong relationships with clinics in Poland, Hungary, and Turkey. Through live and online trainings, international medical tourism events, and internal courses, Klaudia has become a key member of the team, combining content creation, patient support, and clinic partnerships to help people access safe, effective treatment abroad.
by Klaudia Futyma, on 01.08.25
by Klaudia Futyma, on 26.08.25
Contact us
Call us
Chat with us
